NOV-004

N/A

Report date: 2023/03/12 17:11:08
NME

Base Information

Drug NameNOV-004
Drug Alias NameNOV-004
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionOsteoblasts stimulants
TargetsUpdating
Therapy Area/IndicationsOsteogenesis Imperfecta
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovosteo Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovosteo Inc
Inactive CompaniesN/A
Active IndicationsOsteogenesis Imperfecta
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A